Last update:

Oncology news

Breast cancer survivors could avoid lifelong heart medication, research suggests

Many breast cancer survivors whose treatment caused them to develop problems with their heart function can safely stop their medication after their heart recovers, and most won't need to continue treatment long term, according ...

Cardiologist referrals improve cholesterol levels in prostate cancer patients, but may not be necessary for all

Men with prostate cancer have a high risk of heart disease, especially when treated with hormone therapy. A large international, first-of-its-kind study led by Hamilton researchers found that routine referrals to an internist ...

Study tracks early adoption of liver histotripsy treatment

It has been nearly three years since the U.S. Food and Drug Administration (FDA) cleared the HistoSonics Edison histotripsy system to treat primary and metastatic liver tumors. To examine how the technology's adoption and ...

FDA approval opens new chapter in pancreatic cancer treatment

For decades, a diagnosis of metastatic pancreatic cancer left patients and physicians facing the same harsh reality: limited options, difficult treatments and too little time. Now, a pill tested in a global clinical trial ...

Folic acid does not elevate formaldehyde in mice and humans

Folic acid—an essential vitamin added to flour and cereals and prescribed at high doses for cancer patients and people with blood disorders—does not elevate toxic formaldehyde in the body, according to a new study of mice ...

No safe tan: Why Canada's sunburn problem keeps getting worse

Scroll through social media and you will encounter a strange vocabulary for an old impulse: "tanmaxxing," "UV chasing" and "SPF shunning." In some corners of the internet, sunscreen is described as toxic, while a "natural" ...